Addressing unmet needs in rheumatoid arthritis: the challenge of translating multi-omics into precision therapies
{{output}}
Rheumatoid arthritis (RA) is a highly heterogeneous chronic systemic inflammatory disease. Approximately 30-40% of patients exhibit an inadequate response to currently available biologic agents and Janus kinase inhibitors. In recent years, rapid advances in mu... ...
